VIA
ORIC icon

Virtus Investment Advisers’s Oric Pharmaceuticals ORIC Stock Holding History

Virtus Investment Advisers’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$428K Buy
39,565
+10,496
+36% +$95.2K 0.1% 241
2026
Q1 		$368K Buy
29,069
+708
+2% +$8.04K 0.1% 252
2025
Q4 		$232K Buy
28,361
+16,594
+141% +$191K 0.06% 354
2025
Q3 		$141K Buy
11,767
+2,043
+21% +$21.5K 0.04% 386
2025
Q2 		$98.7K Sell
9,724
-9,749
-50% -$65.4K 0.03% 338
2025
Q1 		$109K Buy
+19,473
New +$170K 0.03% 408

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Virtus Investment Advisers's ORIC Position: Q2 2026 in Review

Virtus Investment Advisers increased its Oric Pharmaceuticals (ORIC) stake by 36% in Q2 2026, buying an estimated $95.2K and bringing the position to 39,565 shares worth $428K. The position accounts for 0.1% of the portfolio, ranked #241.

Virtus Investment Advisers first reported a position in ORIC in Q1 2025 and has held it in 6 quarters since. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Virtus Investment Advisers held 39,565 shares of Oric Pharmaceuticals worth $428K as of Q2 2026.
  • Virtus Investment Advisers bought 10,496 Oric Pharmaceuticals shares in Q2 2026, an estimated $95.2K.
  • Oric Pharmaceuticals made up 0.1% of Virtus Investment Advisers's portfolio in Q2 2026, its #241 holding.
  • Virtus Investment Advisers first reported a position in Oric Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.